A
A. Duncan Steele
Researcher at Bill & Melinda Gates Foundation
Publications - 61
Citations - 3067
A. Duncan Steele is an academic researcher from Bill & Melinda Gates Foundation. The author has contributed to research in topics: Rotavirus & Rotavirus vaccine. The author has an hindex of 25, co-authored 61 publications receiving 2317 citations. Previous affiliations of A. Duncan Steele include National Health Laboratory Service & PATH.
Papers
More filters
Journal ArticleDOI
Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years.
Christopher Troeger,Ibrahim A Khalil,Puja C Rao,Shujin Cao,Brigette F. Blacker,Tahmeed Ahmed,George Armah,Julie E Bines,Julie E Bines,Thomas G Brewer,Danny V. Colombara,Gagandeep Kang,Beth D. Kirkpatrick,Carl D. Kirkwood,Jason M. Mwenda,Umesh D. Parashar,William A. Petri,Mark S Riddle,A. Duncan Steele,Robert L. Thompson,Judd L. Walson,John W. Sanders,Ali H. Mokdad,Christopher J L Murray,Simon I. Hay,Simon I. Hay,Robert Reiner +26 more
TL;DR: It is suggested that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection.
Journal ArticleDOI
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016.
Ibrahim A Khalil,Christopher Troeger,Brigette F. Blacker,Puja C Rao,Alexandria Brown,Deborah Atherly,Thomas G Brewer,Cyril Engmann,Cyril Engmann,Eric R. Houpt,Gagandeep Kang,Karen L. Kotloff,Myron M. Levine,Stephen P. Luby,Calman A. MacLennan,William Pan,William Pan,Patricia B Pavlinac,James A Platts-Mills,Firdausi Qadri,Mark S. Riddle,Edward T. Ryan,David A Shoultz,A. Duncan Steele,Judd L. Walson,John W. Sanders,Ali H. Mokdad,Christopher J L Murray,Simon I. Hay,Simon I. Hay,Robert Reiner +30 more
TL;DR: The global burden of shigella and ETEC diarrhoea according to age, sex, geography, and year from 1990 to 2016 is analyzed to assess the health burden of bacterial diarrhoeal pathogens globally.
Journal ArticleDOI
The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control
TL;DR: An expert group was assembled to assess the evidence for the global burden of norovirus and to consider the prospects fornorovirus vaccine development, and the group considered how to bring norov virus vaccines from their current state of development to a viable product that will benefit global health.
Journal ArticleDOI
Real-world impact of rotavirus vaccination.
Manish M. Patel,A. Duncan Steele,Jon R. Gentsch,John Wecker,Roger I. Glass,Umesh D. Parashar +5 more
TL;DR: The sustained declines in disease for 2–3 year after vaccination indicates that duration of protection in thesesettings was sufficient to impact the youngest children, who bear the greatest burden of severe rotavirus diarrheBelgium (20) RV1 65%–83% reduction in rotavirushospitalizationsAustralia (21) RV 1 & RV5 89%–94% vaccine efficacy against rotvirush hospitalizations among children 5; 68%–93% reduced in under-1
Journal ArticleDOI
Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.
Michelle J. Groome,Nicola Page,Margaret M. Cortese,Jocelyn Moyes,Jocelyn Moyes,Heather J. Zar,Constant N Kapongo,Christine Mulligan,Ralph Diedericks,Cheryl Cohen,Cheryl Cohen,Jessica A. Fleming,Mapaseka L. Seheri,Jeffrey Mphahlele,Sibongile Walaza,Kathleen Kahn,Kathleen Kahn,Meera Chhagan,A. Duncan Steele,A. Duncan Steele,A. Duncan Steele,Umesh D. Parashar,Elizabeth R. Zell,Shabir A. Madhi,Shabir A. Madhi +24 more
TL;DR: Human rotvirus vaccine provided sustained protection against admission to hospital for acute rotavirus diarrhoea during the first and second years of life, and was similar in HIV-exposed-uninfected children and HIV-unexp exposed-un Infected children.